Catégories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
L-Canavanine sulfate
(25823277 | 2219-31-0)
CAS: | 2219-31-0 |
---|---|
Formule moléculaire: | C5H14N4O7S |
Masse moléculaire: | 274.25 |
Disponibilité: | Vérifier la disponibilité |
---|---|
Téléchargements: | | |
25823277-100mg | 100mg | £57.80 | |
Commande en vrac |
25823277-100mg | 100mg | €81.00 | |
Commande en vrac |
25823277-100mg | 100mg | $86.70 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 25823277 | ||||
Product Name | L-Canavanine sulfate | ||||
Categories | Amino Acids | ||||
CAS | 2219-31-0 | ||||
Molecular Formula | C5H14N4O7S | ||||
Molecular Weight | 274.25 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29280090 EXP 2928009090 IMP |
Spécifications du produit
Solubility | Clear, colourless (100mg/ml, H2O) | ||||
Nitrogen | 19.7 - 21.1% | ||||
Appearance | White powder | ||||
Purity TLC | >99% | ||||
Water KF | <7% | ||||
Carbon | 21.2 - 22.6% | ||||
For research use only, not for human use | For research use only, not for human use |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|